Dr. Lindsey is a neurologist who is interested in the treatment of multiple sclerosis and other autoimmune diseases affecting the nervous system. He has been on faculty at the University of Texas-Houston since 1993. In addition to taking care of patients with multiple sclerosis and related diseases, he also conducts research on the cause of multiple sclerosis and new treatments for multiple sclerosis.
1978-1981 B.A. in Chemistry, summa cum laude, Rice University, Houston, TX
1985-1986 M.Sc. in Physiology, Oxford University, Oxford, England
Thesis: The effect of prism adaptation on the activity of brainstem near-response neurons.
1982-1987 M.D., Harvard Medical School, Boston, MA
1987-1988 Intern in Medicine, Brigham and Women’s Hospital, Boston, MA
1988-1990 Resident in Neurology, Stanford University Medical Center, Stanford, CA
1990-1991 Chief Resident in Neurology, Stanford University Medical Center, Stanford, CA
1991-1993 Research Fellow in Neuroimmunology with Dr. Lawrence Steinman, Stanford University Medical Center, Stanford, CA
2010-present Professor of Neurology, Clinical Track, University of Texas—Houston Medical School
2018-present Director, Division of Multiple Sclerosis and Neuroimmunology, University of Texas-Houston Medical School
Dr. Lindsey's main laboratory research interest is the role of Epstein-Barr virus in multiple sclerosis. There is an abundance of evidence documenting the association of EBV infection with MS, but how the virus might cause the disease is not clear. One possible mechanism, which is called molecular mimicry, is that part of the virus resembles something in brain tissue, so that white blood cells that are stimulated to attack the virus also attack the brain. Dr. Lindsey's current work is aimed at identifying the cells that cause MS, and determining whether they recognize both brain and virus.